Literature DB >> 9421379

Expression of insulin/IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia.

M Federici1, D Lauro, M D'Adamo, B Giovannone, O Porzio, M Mellozzi, G Tamburrano, P Sbraccia, G Sesti.   

Abstract

The insulin receptor (IR) shares structural and functional homology with the IGF-I receptor (IGF-IR). Hybrid receptors composed of an IR alphabeta-heterodimer and an IGF-IR alphabeta-heterodimer are formed in tissues expressing both molecules. Hybrids behave as IGF-IR rather than IR with respect to ligand binding affinity, receptor autophosphorylation, and hormone internalization and degradation. Factors regulating hybrid formation in vivo are unknown. We recently reported that in skeletal muscle of NIDDM patients, expression of hybrids is increased and correlated with a decrease in IR number and an increase in fasting insulin levels. However, it is not clear whether increased expression of hybrid receptors is a primary defect specifically associated with NIDDM or a secondary event caused by hyperinsulinemia. To address this issue, we used a quantitative microwell-based immunoassay to measure hybrid receptor abundance in skeletal muscle of 11 normal subjects and 12 patients with insulinoma, a state of primary nongenetically determined hyperinsulinemia. Total insulin binding was lower in insulinoma patients than in normal subjects (0.70 +/- 0.18 vs. 4.59 +/- 0.77; P < 0.0001). Total IGF-I binding did not differ between the two groups (0.81 +/- 0.27 and 0.85 +/- 0.10, respectively). The amount of hybrids, expressed as bound/total (B/T), was higher in patients with insulinoma than in normal subjects (0.57 +/- 0.19 vs. 0.36 +/- 0.03; P < 0.0006) and was inversely correlated with total insulin binding (r = -0.64, P < 0.0004). Increased abundance of hybrid receptors was positively correlated with insulin levels (r = -0.82, P < 0.0009) and inversely correlated with insulin-mediated glucose uptake (r = -0.80, P < 0.01). No correlations were observed between insulin-mediated glucose uptake and maximal specific insulin binding (r = 0.19, P = 0.64). These results indicate that insulin-induced IR downregulation may lead to the formation of a higher proportion of hybrid receptors, whose abundance is negatively correlated with in vivo insulin sensitivity. These results, therefore, support a role for insulin in the regulation of hybrid receptors formation and suggest that increased expression of hybrids in NIDDM may be a secondary event caused by hyperinsulinemia rather than a primary defect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9421379     DOI: 10.2337/diab.47.1.87

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  Expression and function of insulin/insulin-like growth factor I hybrid receptors during differentiation of 3T3-L1 preadipocytes.

Authors:  D Modan-Moses; M Janicot; J C McLenithan; M D Lane; S J Casella
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

2.  Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes.

Authors:  Yevgeniya S Kushchayeva; Sergiy V Kushchayev; Megan Startzell; Elaine Cochran; Sungyoung Auh; Yuhai Dai; Marissa Lightbourne; Monica Skarulis; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

3.  Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes.

Authors:  A M Fernández; J K Kim; S Yakar; J Dupont; C Hernandez-Sanchez; A L Castle; J Filmore; G I Shulman; D Le Roith
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

4.  Partial rescue of in vivo insulin signalling in skeletal muscle by impaired insulin clearance in heterozygous carriers of a mutation in the insulin receptor gene.

Authors:  K Højlund; J F P Wojtaszewski; J Birk; B F Hansen; H Vestergaard; H Beck-Nielsen
Journal:  Diabetologia       Date:  2006-06-08       Impact factor: 10.122

Review 5.  The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.

Authors:  Swapnil N Rajpathak; Marc J Gunter; Judith Wylie-Rosett; Gloria Y F Ho; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Howard D Strickler
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

Review 6.  The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium.

Authors:  V Kate Gatenby; Helen Imrie; Mark Kearney
Journal:  Pflugers Arch       Date:  2013-01-22       Impact factor: 3.657

Review 7.  Modulation of insulin action.

Authors:  L Pirola; A M Johnston; E Van Obberghen
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

8.  Insulin-like growth factor axis and risk of type 2 diabetes in women.

Authors:  Swapnil N Rajpathak; Meian He; Qi Sun; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Marc J Gunter; Michael Pollak; Mimi Kim; Jeffrey E Pessin; Jeannette Beasley; Judith Wylie-Rosett; Frank B Hu; Howard D Strickler
Journal:  Diabetes       Date:  2012-05-03       Impact factor: 9.461

9.  The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium.

Authors:  Afroze Abbas; Helen Imrie; Hema Viswambharan; Piruthivi Sukumar; Adil Rajwani; Richard M Cubbon; Matthew Gage; Jessica Smith; Stacey Galloway; Nadira Yuldeshava; Matthew Kahn; Shouhong Xuan; Peter J Grant; Keith M Channon; David J Beech; Stephen B Wheatcroft; Mark T Kearney
Journal:  Diabetes       Date:  2011-06-15       Impact factor: 9.461

10.  Study of insulin resistance in relation to serum IGF-I levels in subjects with different degrees of glucose tolerance.

Authors:  Srinivas Martha; Narayana Pantam; Surender Thungathurthi; Vummentala L N Rao; Krishna Devarakonda
Journal:  Int J Diabetes Dev Ctries       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.